AKT1 and cancer: The phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of the rapamycin (mTOR) signaling pathway is activated in human cancers, which participates in many cellular processes, such as cell survival, metastasis, autophagy, metabolism, and angiogenesis [10].